Blog

Careers

Advertise

Contact

logo
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • Events
    • National Pharmacy Forum 2021
    • Past Events
  • CHeS
    • CHeS Total Visibility Project
    • CHeS Membership
    • CHeS Resources
  • Issues
  • Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • Small Supplier Portal
    • Congressional Resources
    • COVID-19 Recommendations
  • News
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • Events
    • National Pharmacy Forum 2021
    • Past Events
  • CHeS
    • CHeS Total Visibility Project
    • CHeS Membership
    • CHeS Resources
  • Issues
  • Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • Small Supplier Portal
    • Congressional Resources
    • COVID-19 Recommendations
  • News

HSCA Applauds House Judiciary Committee for Advancing the CREATES Act

April 30, 2019 by Elizabeth Landau Uncategorized 0 comments

Washington, DC (April 30, 2019) – Healthcare Supply Chain Association (HSCA) President and CEO
Khatereh Calleja today released the following statement applauding the House Judiciary Committee
members for voting to advance the CREATES Act (H.R. 965):

“The Healthcare Supply Chain Association (HSCA) and its member group purchasing organizations
(GPOs) applaud Chairman Nadler, Ranking Member Collins, and the members of the House Judiciary
Committee for helping to increase competition in the generic drug marketplace by voting to advance the
CREATES Act. Americans rely on generic drugs to reduce costs and increase access to necessary
medication, and price spikes for commonly used drugs jeopardize patient access to care. HSCA supports
policy solutions like the CREATES Act that lower drug prices, encourage competition and innovation in
the marketplace, and end anti-competitive abuses utilized by some brand-name manufacturers. We
urge the House to quickly pass the CREATES Act to protect patient access to essential medications.”

 

Read the full statement here.

Prev
Next

Related Posts

Joint Letter of Support for the MEDS Act
November 5, 2019

Dear Senator Collins and Senator Smith, The undersigned organizations are...

Learn more
HSCA Statement on Senate HELP Committee Hearing on the Coronavirus
March 3, 2020

Washington, DC (March 3, 2020) – Healthcare Supply Chain Association (HSCA)...

Learn more
HSCA Applauds House Judiciary Committee for Advancing the CREATES Act
April 30, 2019

Washington, DC (April 30, 2019) – Healthcare Supply Chain Association (HSCA)...

Learn more
HSCA Applauds Senators Collins and Smith for Bipartisan Legislation to Prevent and Mitigate Drug Shortages
October 30, 2019

Washington, DC (October 30, 2019) – Healthcare Supply Chain Association (HSCA)...

Learn more

Our Office

Healthcare Supply Chain Association
1341 G Street NW Suite 600
Washington, DC 20005

Phone: 202.629.5833
Fax: 202.466.9666
Email: info@supplychainassociation.org

LATEST NEWS

  • HSCA Submits Comments to FDA on Using Unique Device Identifiers in Medical Device Safety Communications to Support Accuracy, Quality, and Patient Safety
    January 18, 2021
  • HSCA Comments to the U.S. ITC on COVID-19 Related Goods: The U.S. Industry, Market, Trade, and Supply Chain Challenges
    October 5, 2020